For years pharmaceutical companies have been abusing the patent system to delay and eliminate competition from generic medicines and boost their own profits. The latest trend takes this abuse to a whole new level, as Pharma is now weaponizing patents to sue generic firms over and over and over again, even after losing every time.
Pharma's patent and litigation abuse prevents and delays Americans from getting affordable medicines and costs all of us billions of dollars every year.
Stop Big Pharma’s newest abusive practice - serial patent litigation
Help Americans get the affordable medicines they need
Save governments, patients, employers, and all taxpayers billions of dollars every year
In 2023 alone, generics saved the U.S. healthcare system $432 billion in prescription drug costs; between 2009 and 2019, generic drugs saved the U.S. healthcare system nearly $2.2 trillion. These savings result from generics costing 80 to 85 percent less than their branded counterparts.
Read MoreRealClearHealth
Conservatives Must Rally Behind Generic DrugsGeneration Patient
Serial Patent Litigation: How Repeated Lawsuits Block Patient Access to Affordable MedicinesPharmaceutical-Technology.com
How sham patents are hurting the pharma industryThe American Prospect
How Big Pharma Rigged the Patent SystemWVUToday
In the case of brand name drugs versus generics, patents can be bad medicine, WVU law professor saysWCRN Boston, The Joe Mangiacotti Show
Scottie Nell Hughes discusses pharmaceutical patent abuseAmerica First Policy Institute
Patent Abuses Keep Prescription Drugs UnaffordableThe Coalition Against Pharma Patent Abuse is an alliance of patient, employer, and affordable healthcare advocacy organizations leading the fight for federal legislation to:
Stop Big Pharma serial patent litigation
Help Americans get the medicines they need
Save taxpayers billions of dollars every year